PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Rise of the Vox Populi

Can Competition Block Excessive Pharma Price Hikes? EpiPen Saga Shows It's Hard

Content Marketing: Too Big for Pharma to Ignore

Executive Profile

Pharm Exec's Emerging Pharma Leaders 2016

Pharm Exec's 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable—or complacent.
... /Read more/

Pricing & Reimbursement

Opioid Epidemic: More Finger Pointing at the Pharma Industry

Traditional sales and pricing practices face legal challenges and political backlash.
... /Read more/

Regulatory Affairs

Brexit Report: What's Next for the Industry?

As the UK exits the European Union, pharma should prepare for changes by identifying key business issues, mitigating risks and creating plans for multiple scenarios.
... /Read more/

Legal Affairs

Sunshine Data Helps Feds Uncover Fraud

$7.5 billion in pharma "transfers of value" made in 2015 has caught the attention of the DoJ and federal/state prosecutors investigating fraud.
... /Read more/

Calendar

/ World Drug Safety Congress Europe 2016 /

/ Compliance Congress for Specialty Products /

/ 4th Annual Coupon and Co-Pay Offer Design Optimization /

/ Lay Summaries Summit 2016 /

/ Financial Reporting for Emerging and Later-Stage Life Sciences Companies /

/ PAP Legal Update /

/ Real World Evidence 2016 /

Reputation

Celldex Therapeutics: Vying for the Triple Aim in Cancer Care

Pharm Exec sits down with Anthony Marucci, co-founder and CEO of Celldex, a stealth player in the immunotherapy field.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com